| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |